Health Trials

Advanced Solid Tumors and Hematologic Malignancies

1

Review clinical trials related to Advanced Solid Tumors and Hematologic Malignancies. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Safety, Tolerability, Pharmacokinetic Characteristics, and Efficacy of CM369 in Advanced Solid Tumors & Hematologic Malignancies

This is a nonrandomized, open-label, multicenter, phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics, and efficacy of CM369 in subjects with advanced solid tumors and Hematologic Malignancies.

Participants needed: 146
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Beijing InnoCare Pharma Tech Co., Ltd.Updated: Dec 27, 2024Locations: 3
Eligibility criteria

Life expectancy ≥12 weeks. [+17]

Subjects with primary central nervous system (CNS) tumors or unstable CNS metast... [+32]

Read more